CN102657750B - Chinese medicinal composition for treating urinary tract infection - Google Patents

Chinese medicinal composition for treating urinary tract infection Download PDF

Info

Publication number
CN102657750B
CN102657750B CN201210141538.5A CN201210141538A CN102657750B CN 102657750 B CN102657750 B CN 102657750B CN 201210141538 A CN201210141538 A CN 201210141538A CN 102657750 B CN102657750 B CN 102657750B
Authority
CN
China
Prior art keywords
parts
chinese
urinary tract
medicinal composition
tract infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201210141538.5A
Other languages
Chinese (zh)
Other versions
CN102657750A (en
Inventor
张殊文
刘荣芬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ningguo Jisi Intellectual Property Operation Co ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210141538.5A priority Critical patent/CN102657750B/en
Publication of CN102657750A publication Critical patent/CN102657750A/en
Application granted granted Critical
Publication of CN102657750B publication Critical patent/CN102657750B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the technical field of Chinese medicaments, and aims to provide a Chinese medicinal composition with scientific and simple compatibility and good curative effect according to the cognition mechanism of Chinese medicine on urinary tract infection. The Chinese medicinal composition consists of the following Chinese herbal medicines in part by weight: 18 to 22 parts of morinda officinalis, 28 to 32 parts of dipsacus root, 18 to 22 parts of dandelion, 12 to 18 parts of acorus gramineus, 12 to 18 parts of atractylodes, 12 to 18 parts of big-head atractylodes rhizome, 12 to 18 parts of weeping forsythia, 28 to 32 parts of sow thistle, 12 to 18 parts of plantain seed, 12 to 18 parts of dianthus superbus, 12 to 18 parts of polygonum aviculare, 9 to 15 parts of gardenia, and 8 to 12 parts of liquorice. The invention has the advantages that the Chinese medicinal composition is definite in curative effect, does not have obvious adverse reaction, and is good in application compliance of patients and beneficial to treatment and consolidation of diseases.

Description

A kind of Chinese medicine composition for the treatment of urinary tract infection
Technical field
The invention belongs to technical field of Chinese medicines, specifically refer to a kind of Chinese medicine composition for the treatment of urinary tract infection.
Background technology
Urinary tract infection, is called for short urine sense, refers to the urinary tract inflammation that pathogen infringement urinary tract mucosa or tissue cause.According to infection site, urinary tract infection can be divided into upper urinary tract infection and lower urinary tract infection, and the former is pyelonephritis, and the latter is mainly cystitis.
The traditional Chinese medical science to the understanding of urinary tract infection one disease is: the cause of disease of primary disease be take damp and hot as main, and sick position is at bladder and kidney, and relevant with liver spleen etc.Its pathogenesis is mainly the damp-heat accumulation part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels, and the mechanism of qi that is jammed causes functioning of bladder unfavorable, if with the passing of time disease prolongs, damp and hotly also can fumigate in kidney, and the gas that consumption is impairment of the kidney is cloudy.
Summary of the invention
The object of the invention is the understanding mechanism to urinary tract infection one disease according to the traditional Chinese medical science, the Chinese medicine composition of simple, eutherapeutic this disease for the treatment of of a kind of compatibility science is provided.
For realizing above-mentioned technical purpose, the technical solution used in the present invention is: a kind of Chinese medicine composition for the treatment of urinary tract infection, is characterized in that: this Chinese medicine composition is to adopt the material medicine of following weight proportion to combine: Radix Morindae Officinalis 18-22, Radix Dipsaci 28-32, Herba Taraxaci 18-22, Rhizoma Acori Graminei 12-18, Rhizoma Atractylodis 12-18, Rhizoma Atractylodis Macrocephalae 12-18, Fructus Forsythiae 12-18, Herba Ixeritis chinensis 28-32, Semen Plantaginis 12-18, Herba Dianthi 12-18, Herba Polygoni Avicularis 12-18, SHANZHIZI 9-15, Radix Glycyrrhizae 8-12.
The instructions of taking of this Chinese medicine composition is: after the material medicine of aforementioned proportion is mixed, adopt the method for traditional fried Chinese medicine to get its medicine juice, every pair 350-500ml that takes concoction, minute takes for twice sooner or later, every day one pair.
What in Chinese medicine composition provided by the present invention, effect diarrhea Jiao of the relieving stranguria by diuresis of , Qu Herba Polygoni Avicularis, Herba Dianthi, Semen Plantaginis, tonneau bladder pented up is damp and hot; Get Rhizoma Acori Graminei, Rhizoma Atractylodis, Rhizoma Atractylodis Macrocephalae removing dampness appetizing, invigorating the spleen and benefiting QI; Get Fructus Forsythiae, Herba Ixeritis chinensis, SHANZHIZI and carry out heat-clearing and toxic substances removing; For preventing that the damp and hot of the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels from letting out and injuring Liver and kidney too down, in Chinese medicine composition provided by the invention, utilized again Radix Morindae Officinalis, Radix Dipsaci to carry out invigorating the liver and kidney, bone and muscle strengthening, thereby reach in letting out, there is benefit.By strengthening the spleen and stomach, let out damp and hotly, recover the gasification function of bladder, thereby reach the technical purpose for the treatment of urinary tract infection.
Beneficial effect of the present invention is: curative effect is sure, and without obvious adverse reaction, it is good that patient applies compliance, is beneficial to treatment, the consolidation of disease.
The specific embodiment
Below in conjunction with embodiment and practical situation, the present invention will be further described.
According to prescription requirement of the present invention, in 20 parts of weight portion proportioning Radix Morindae Officinaliss, 30 parts of Radix Dipsaci, 20 parts of Herba Taraxacis, 15 parts of Rhizoma Acori Graminei, 15 parts of Rhizoma Atractylodis, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Fructus Forsythiaes, 30 parts of Herba Ixeritis chinensiss, 15 parts of Semen Plantaginiss, Herba Dianthi 15 15 parts of Fen, Herba Polygoni Avicularis, 12 parts of SHANZHIZI, 10 parts, Radix Glycyrrhizae.
1, alternative
1.1 diagnostic criterias: comprise that the bladder irritations such as frequent micturition, urgent micturition, dysurea levy, lumbago and
(or) hypogastric region pain, sometimes with shiver with cold, heating, headache, feel sick, vomiting,
The symptoms such as inappetence; Centrifugal rear urinary sediment microscopy leukocyte >5/HP)+urine nitrite experiment the positive, meet urinary tract infection symptom.
The inclusive criteria age was at 22 years old-63 years old.
1.2 are divided into treatment by Chinese herbs group and western medicine group at random, treatment by Chinese herbs group 38 examples, age 35-63 year, mean age (49.67 ± 4.21 years old), the course of disease 1.40 ± 0.88 years; Western medicine group 13 examples, age 22-50 year, mean age (38.52 ± 1.02 years old), the course of disease 1.68 ± 1.02 years.
2. method
2.1 medicine
Chinese medicine preparation Radix Morindae Officinalis 20g, Radix Dipsaci 30g, Herba Taraxaci 20g, Rhizoma Acori Graminei 15g, Rhizoma Atractylodis 15g, Rhizoma Atractylodis Macrocephalae 15g, Fructus Forsythiae 15g, Herba Ixeritis chinensis 30g, Semen Plantaginis 15g, Herba Dianthi 15g, Herba Polygoni Avicularis 15g, SHANZHIZI 12g, Radix Glycyrrhizae 10g are as a pair.Western medicine levofloxacin+nitrofurantoin.
2.2 Therapeutic Method
Treatment by Chinese herbs group: get Chinese medicine composition provided by the invention, every day one, pair, took its medicine juice, take for twice every day sooner or later, within 7th, is a course for the treatment of.
Western medicine group: levofloxacin 300mg every day, twice intravenous drip+nitrofurantoin was 0.1g/ time, 4 times/day.
2.3 observation item
Before and after treatment, the change of state of an illness symptom and centrifugal rear urinary sediment microscopy quantity of leucocyte, the experiment of urine nitrite turn negative.
Result:
? number of cases therapeutic outcome on the 7th therapeutic outcome on the 14th therapeutic outcome on the 21st recurrence half a year statistics
treatment by Chinese herbs group 38 the physical symptoms such as the whole urine urgency-frequencies of 38 example greatly alleviate, 5/HP of the 28 centrifugal rear urinary sediment microscopy leukocyte < of example), 21 example urine nitrite experiment feminine genders. the physical symptoms such as the whole urine urgency-frequencies of 32 example disappear, wherein 5/HP of the 30 centrifugal rear urinary sediment microscopy leukocyte < of example), nitrite experiment is negative. in 38 examples 36 examples all the physical symptom such as urine urgency-frequencies disappear, 5/HP of centrifugal rear urinary sediment microscopy leukocyte <), nitrite experiment is negative, reaches rehabilitation standard; 2 routine symptoms are improved, and centrifugal rear urinary sediment microscopy quantity of leucocyte reduces, but still higher than 5/HP, nitrite is tested 1 example and turned out cloudy, and 1 example is still positive 36 routine rehabilitations have no recurrence.
western medicine group 13 the physical symptoms such as 5 routine urine urgency-frequencies improve, 5/HP of the 2 centrifugal rear urinary sediment microscopy leukocyte < of example), 1 example urine nitrite experiment is negative. the physical symptoms such as 8 routine urine urgency-frequencies disappear, 5/HP of the 5 centrifugal rear urinary sediment microscopy leukocyte < of example), nitrite experiment is negative. the physical symptoms such as 9 routine urine urgency-frequencies disappear, 5/HP of centrifugal rear urinary sediment microscopy leukocyte <), nitrite experiment is negative; But nitrite experiment is positive 2 example centrifugal rear urinary sediment microscopy leukocyte < 5/HP); 5/HP of the 2 centrifugal rear urinary sediment microscopy leukocyte > of example), nitrite experiment is positive; in 9 examples, 7 example recurrences, need to treat again.
By the above results, relatively can find out and adopt this Chinese medicine composition to be obviously better than the treatment of Western medicine to this disease to the therapeutic effect of urinary tract infection one disease, and treatment by Chinese herbs has advantages of instant effect, is difficult for recurrence.
Each raw material Chinese medicinal components providing in this embodiment, this Chinese medicine composition can also adopt following component to carry out prescription:
1,18 parts of Radix Morindae Officinaliss, 32 parts of Radix Dipsaci, 18 parts of Herba Taraxacis, 18 parts of Rhizoma Acori Graminei, grey
12 parts of arts, 18 parts of the Rhizoma Atractylodis Macrocephalaes, 12 parts of Fructus Forsythiaes, 32 parts of Herba Ixeritis chinensiss, 12 parts of Semen Plantaginiss, Herba Dianthi 18 12 parts of Fen, Herba Polygoni Avicularis, 15 parts of SHANZHIZI, 8 parts, Radix Glycyrrhizae.
2,22 parts of Radix Morindae Officinaliss, 28 parts of Radix Dipsaci, 22 parts of Herba Taraxacis, 12 parts of Rhizoma Acori Graminei, 18 parts of Rhizoma Atractylodis, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 18 parts of Fructus Forsythiaes, 28 parts of Herba Ixeritis chinensiss, 18 parts of Semen Plantaginiss, Herba Dianthi 12 18 parts of Fen, Herba Polygoni Avicularis, 9 parts of SHANZHIZI, 12 parts, Radix Glycyrrhizae.

Claims (1)

1. a Chinese medicine composition for the treatment of urinary tract infection, is characterized in that: this Chinese medicine composition is to adopt the material medicine of following weight proportion to combine: Radix Morindae Officinalis 18-22, Radix Dipsaci 28-32, Herba Taraxaci 18-22, Rhizoma Acori Graminei 12-18, Rhizoma Atractylodis 12-18, Rhizoma Atractylodis Macrocephalae 12-18, Fructus Forsythiae 12-18, Herba Ixeritis chinensis 28-32, Semen Plantaginis 12-18, Herba Dianthi 12-18, Herba Polygoni Avicularis 12-18, SHANZHIZI 9-15, Radix Glycyrrhizae 8-12.
CN201210141538.5A 2012-05-09 2012-05-09 Chinese medicinal composition for treating urinary tract infection Expired - Fee Related CN102657750B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210141538.5A CN102657750B (en) 2012-05-09 2012-05-09 Chinese medicinal composition for treating urinary tract infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210141538.5A CN102657750B (en) 2012-05-09 2012-05-09 Chinese medicinal composition for treating urinary tract infection

Publications (2)

Publication Number Publication Date
CN102657750A CN102657750A (en) 2012-09-12
CN102657750B true CN102657750B (en) 2014-08-13

Family

ID=46767418

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210141538.5A Expired - Fee Related CN102657750B (en) 2012-05-09 2012-05-09 Chinese medicinal composition for treating urinary tract infection

Country Status (1)

Country Link
CN (1) CN102657750B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101152472A (en) * 2007-09-17 2008-04-02 尹克山 Traditional Chinese medicine for treating pregnancy complicated with urinary tract infection

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101152472A (en) * 2007-09-17 2008-04-02 尹克山 Traditional Chinese medicine for treating pregnancy complicated with urinary tract infection

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
中医药治疗非淋菌性尿道炎研究概况;林海峰;《广西中医学院学报》;20051231;第8卷(第2期);77-80 *
尿路感染的中医药治疗概况;杨宗善;《陕西中医》;19891231;第10卷(第1期);40-42 *
杨宗善.尿路感染的中医药治疗概况.《陕西中医》.1989,第10卷(第1期),40-42.
林海峰.中医药治疗非淋菌性尿道炎研究概况.《广西中医学院学报》.2005,第8卷(第2期),77-80.

Also Published As

Publication number Publication date
CN102657750A (en) 2012-09-12

Similar Documents

Publication Publication Date Title
CN103330865B (en) Medicine for curing non-alcoholic steatohepatitis and preparation method thereof
CN103690741A (en) Pharmaceutical composition for treating gout and gouty arthritis
CN103127422B (en) Medicament for treating ulcerative colitis
CN104027517A (en) Traditional Chinese medicine for treating acute enteritis
CN103705689A (en) Drug composition for treating gout and gouty arthritis
CN103690710A (en) Pharmaceutical composition for treating gout and gouty arthritis
CN101804189B (en) Drug for treating primary dysmenorrhea
CN102657750B (en) Chinese medicinal composition for treating urinary tract infection
CN103142839B (en) A kind of Chinese medicinal formulae for the treatment of impotence and premature ejaculation
CN101829249A (en) Traditional Chinese medicine powder for treating rheumatoid diseases
CN104258275A (en) Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis
CN105343806A (en) Traditional Chinese medicine preparation for treating gastritis and gastric ulcer
CN105641419A (en) Traditional Chinese medicine composition for treating Yin deficiency type cough caused by lung cancer
CN104840927A (en) Traditional Chinese medicine for treating chronic erosive gastritis
CN104352994A (en) Pharmaceutical preparation for sexual dysfunction
CN103690744A (en) Pharmaceutical composition for treating gout and gouty arthritis
CN102824460A (en) Medicine for treating urticaria
CN102698129B (en) Traditional Chinese medicine composition for treating postoperative intestinal adhesion
CN102379965A (en) Traditional Chinese medicine for treating chronic prostatitis
CN101983676A (en) Medicament for treating gynecological blood stasis and qi stagnation
CN105663838A (en) Traditional Chinese medicine for treating choledocholithiasis by combining epidural anesthesia and preparation method
CN104758455A (en) Traditional Chinese medicine composition for treating chronic gastritis
CN104623506A (en) Traditional Chinese medicine for treating infertility gynaecopathia
CN104189624A (en) Traditional Chinese medicine for treating pelvic inflammation
CN104587256A (en) Traditional Chinese medicine composition for treating prostatitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: LIU RONGFEN

Free format text: FORMER OWNER: RONGCHENG SHANGMAOCHENG HEALTH CENTER

Effective date: 20140609

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Liu Rongfen

Inventor after: Zhao Yan

Inventor after: Zhang Xiaoling

Inventor after: Lin Rongbo

Inventor before: Lin Rongbo

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: LIN RONGBO TO: LIU RONGFEN ZHAO YAN ZHANG XIAOLING LIN RONGBO

Free format text: CORRECT: ADDRESS; FROM: 264300 WEIHAI, SHANDONG PROVINCE TO: 264200 WEIHAI, SHANDONG PROVINCE

TA01 Transfer of patent application right

Effective date of registration: 20140609

Address after: 264200, Rongcheng, Shandong province Weihai city Shidao Management Zone double Bang East Road No. 199

Applicant after: Liu Rongfen

Address before: 264300 Health Center, Rongcheng Trade Center, Weihai, Shandong

Applicant before: Rongcheng Trade City Health Center

ASS Succession or assignment of patent right

Owner name: ZHANG SHUWEN

Free format text: FORMER OWNER: LIU RONGFEN

Effective date: 20140703

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Zhang Shuwen

Inventor after: Liu Rongfen

Inventor before: Liu Rongfen

Inventor before: Zhao Yan

Inventor before: Zhang Xiaoling

Inventor before: Lin Rongbo

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: LIU RONGFEN ZHAO YAN ZHANG XIAOLING LIN RONGBO TO: ZHANG SHUWEN LIU RONGFEN

TA01 Transfer of patent application right

Effective date of registration: 20140703

Address after: 264200, room 31, building No. 403, lotus pond south, Rongcheng, Shandong, Weihai

Applicant after: Zhang Shuwen

Address before: 264200, Rongcheng, Shandong province Weihai city Shidao Management Zone double Bang East Road No. 199

Applicant before: Liu Rongfen

C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20151229

Address after: 637400, No. 2, building 2, building 4, 2, East Temple, 8 East Street, Shoushan temple, Nanchong, Sichuan, Langzhong

Patentee after: Wang Lihua

Address before: 264200, room 31, building No. 403, lotus pond south, Rongcheng, Shandong, Weihai

Patentee before: Zhang Shuwen

C56 Change in the name or address of the patentee
CP02 Change in the address of a patent holder

Address after: 225300 Taizhou science and Technology Park, Jiangsu high tech Park revitalization Avenue, No. 197

Patentee after: Wang Lihua

Address before: 637400, No. 2, building 2, building 4, 2, East Temple, 8 East Street, Shoushan temple, Nanchong, Sichuan, Langzhong

Patentee before: Wang Lihua

TR01 Transfer of patent right

Effective date of registration: 20190923

Address after: Room 501, Office Building of Market Supervision Bureau of Langchuan Avenue, Jianping Town, Langxi County, Xuancheng City, Anhui Province

Patentee after: Xuancheng Geith Intellectual Property Operations Co.,Ltd.

Address before: 225300 Taizhou science and Technology Park, Jiangsu high tech Park revitalization Avenue, No. 197

Patentee before: Wang Lihua

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20201201

Address after: Ji'an City, Jiangxi province 343900 area Suichuan County Yunling industry

Patentee after: JIANGXI SUICHUAN LIGHT VELOCITY ELECTRONIC Co.,Ltd.

Address before: Room 501, Office Building of Market Supervision Bureau of Langchuan Avenue, Jianping Town, Langxi County, Xuancheng City, Anhui Province

Patentee before: Xuancheng Geith Intellectual Property Operations Co.,Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20201217

Address after: Room 303, 3rd floor, West, building 16, electronic information industrial park, heli Park, Ningguo Economic and Technological Development Zone, Xuancheng City, Anhui Province

Patentee after: Ningguo Jisi Intellectual Property Operation Co.,Ltd.

Address before: 343900 Yunling industrial concentration area, Suichuan County, Ji'an, Jiangxi

Patentee before: JIANGXI SUICHUAN LIGHT VELOCITY ELECTRONIC Co.,Ltd.

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140813